七味白术散合痛泻要方加味治疗腹泻型肠易激综合征临床研究  被引量:7

Clinical Research on Treatment of Diarrhea-Predominant Irritable Bowel Syndrome with Qiwei Baizhu Powder andTongxie Yaofang

在线阅读下载全文

作  者:彭树灵[1] 黄红珍[1] 林锦春[1] 刘丽丽[1] 

机构地区:[1]佛山市第二人民医院,广东佛山528000

出  处:《辽宁中医药大学学报》2013年第8期187-189,共3页Journal of Liaoning University of Traditional Chinese Medicine

摘  要:目的:观察七味白术散合痛泻要方加味治疗腹泻型肠易激综合征(D-IBS)的疗效。方法:67例D-IBS患者完全随机分为观察组(n=34)与对照组(n=33)。观察组给予七味白术散合痛泻要方加味治疗,1剂/d;对照组给予匹维溴铵50 mg,3次/d;两组疗程均为8周。比较两组治疗前与治疗2、4、8周后腹痛评分、腹泻评分、症状总评分及总有效率的差异。结果:与治疗前比较,两组腹痛、腹泻评分及症状总评分在治疗2、4、8周后均显著降低(P<0.01);治疗2周后,观察组的腹泻评分及症状总评分显著低于对照组(P<0.01);治疗4、8周后,观察组的腹痛、腹泻评分及症状总评分均显著低于对照组(P<0.01);治疗8周后,观察组的总有效率显著高于对照组(P<0.05),而两组不良反应发生率无显著性差异(P>0.05)。结论:七味白术散合痛泻要方加味治疗腹泻型肠易激综合征疗效显著,无明显不良反应。Objective:To observe the therapeutic effect on diarhea-predominant irritable bowel syndrome ( D-IBS ) with Qiwei Baizhu Powder and Tongxie Yaofang. Methods : 67 patients with D-IBS were randomly divided into observing group ( n=34 ) and control group ( n=33 ). The former was treated with Qiwei Baizhu Powder and Tongxie Yaofang ( 1 dose per day ), and the latter with Pinaverium bromide ( 50 mg, three times a day ). Both groups were treated for 8 weeks, to compare the scores of abdominal pain, diarrhea and con-symptom before and after treated for 2,4 and 8 weeks in both groups, and to compare the total effective and side-effect rate of the two groups after 8 weeks' treatment. Results : The scores of abdominal pain, diarrhea and con-symptom were decreased significantly after treated for 2,4 and~ 8 weeks, compared to those before treatment in each group (P〈0.01). Compared to control group, the scores of diarrhea and con-symptom in observing group were decreased significantly after 2 weeks' treatment( P〈0.01 ). At the end of week 4 and 8, the scores of the three items in observing group were all significantly lower than those of control group (P〈0.01). After 8 weeks' treatment, the total effective rate in observing group was significantly higher than that of control group ( P〈0.05 ), with no significant difference in side-effect rate ( P〉0.05 ). Conclusion : The therapeutic effect on D-IBS with Qiwei Baizhu Powder and Tongxie Yao^ang was notable, without obvious side effect.

关 键 词:肠易激综合征 腹泻 七味白术散 痛泻要方 疗效 

分 类 号:R442.2[医药卫生—诊断学]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象